Physician profile
Kristine Mulingbayan
NPI 1124457254
$666.59
in general payments reported to CMS, 2019-2025
11 companies · $258 in 2025
The $258 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $175 · 2022: $134 · 2024: $99.94 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $357.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $182.25 | 2021-2025 | |
| Viiv Healthcare Company | $108.76 | 2022-2025 | Apretude |
| Takeda Pharmaceuticals U.S.A., INC. | $86.43 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $78.60 | 2025 | Caplyta |
| Abbvie INC. | $61.24 | 2024-2025 | |
| Pfizer INC. | $46.16 | 2024-2025 | |
| Inspire Medical Systems, INC. | $28.03 | 2025 | Inspire |
| Exact Sciences Corporation | $24.93 | 2025 | The Cologuard Plus Collection Kit |
| Janssen Pharmaceuticals, INC | $24.90 | 2021 | |
| Hologic Sales and Service, LLC | $18.14 | 2022 | |
| Genentech USA, INC. | $7.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristine Mulingbayan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.